KMT2A and acute lymphoblastic leukemia: In this setting, given that ALL-MLL+ cases present both high levels of FLT3 and high sensitivity to Ara-C, we hypothesized that FLT3 is a suitable candidate to modulate hNT expression and activity, thereby contributing to cell chemosensitivity.